Unknown NA INTERVENTIONAL 2-arm NCT04463784

Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV Infection

Peking Union Medical College Hospital

Sponsor: Peking Union Medical College Hospital

Interventions Efavirenz 400Mg Oral Tablet Efavirenz 600Mg Oral Tablet

Updated 5 times since 2020 Last updated: Jul 3, 2020 Started: Apr 1, 2018 Primary completion: Dec 31, 2020 Completion: Aug 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates HIV/AIDS and Mental Impairment and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Sep 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Sep 2022 [monthly]

Active Not Recruiting NA
Aug 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China